Abstract: The present invention relates to a novel combination of rifaximin and probiotic yeast, the pharmaceutical compositions containing the combination as well as their use in therapy, in particular in the prevention and/or treatment of intestinal diseases.
Abstract: The present invention relates to a novel combination of salified butyric acid and yeast, the pharmaceutical and nutraceutical compositions containing the combination as well as their use in the prevention and treatment of intestinal diseases.
© 2026 Justia
